Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
1.74 USD
-17.54%
Market Closed
Updated:
May 21, 2024
Compugen Ltd
Net Income
|
Compugen Ltd
Net Income Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Net Income
-$33.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Net Income
-$8.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Net Income
-₪27.5m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
1%
|
See Also
What is Compugen Ltd's Net Income?
Net Income
-33.5m
USD
-33.5m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Net Income amounts to -33.5m USD.
What is Compugen Ltd's Net Income growth rate?
Net Income CAGR 10Y
-9%
-9%
Over the last year, the Net Income growth was 1%. The average annual Net Income growth rates for Compugen Ltd have been -7% over the past three years , -8% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
